Tiziana Life Sciences Ltd. Common Shares (TLSA) Stock Price, Quote & AI Analysis
Live TLSA stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Tiziana Life Sciences Ltd. Common Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for Tiziana Life Sciences Ltd. Common Shares (TLSA), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Tiziana Life Sciences Ltd. Common Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Tiziana Life Sciences Ltd. Common Shares Overview
Company information
Company Overview
Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in developing therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer’s. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Tiziana Life Sciences Ltd. Common Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...